Last updated: December 7, 2024
Sponsor: University Hospital of Ferrara
Overall Status: Active - Recruiting
Phase
N/A
Condition
Mitral Valve Regurgitation
Heart Valve Disease
Treatment
diagnostic flow
Clinical Study ID
NCT04916535
367/2021/Oss/AOUFe
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion criteria:
Subject aged ≥18 years and <65 years
Evidence of MAD during routine echocardiography clinically indicated by treatingphysician for any reason
Written informed consent
Exclusion
Exclusion criteria:
• Patient's refusal
Study Design
Total Participants: 200
Treatment Group(s): 1
Primary Treatment: diagnostic flow
Phase:
Study Start date:
June 03, 2021
Estimated Completion Date:
June 30, 2029
Study Description
Connect with a study center
Cardiology Unit
Bologna,
ItalyActive - Recruiting
University Hospital of Ferrara
Ferrara, 44124
ItalyActive - Recruiting
Morgagni Hospital
Forlì,
ItalyActive - Recruiting
Cardiology Unit
Palermo,
ItalyActive - Recruiting
Santa Maria delle Croci Hospital
Ravenna,
ItalyActive - Recruiting
Cardiology Unit
Rimini,
ItalyActive - Recruiting
University Hospital fo Trieste
Trieste,
ItalyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.